{"entity":{"type":"insider","cik":"0001621222","url":"/insider/0001621222","json_url":"/insider/0001621222.json","name":"Hall Shannon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2015-09-10","last":"2022-12-09","span_basis":"filed_date"},"name_variants":[{"name":"Hall Shannon","source":"filing","n_filings":10,"first_seen":"2015-09-10","last_seen":"2022-12-09"}],"transactions":[{"id":6640545,"accession":"0001228924-22-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001228924-22-000044","line_url":"/filing/0001228924-22-000044#line-1","is_derivative":false,"issuer_cik":"0000724004","issuer_name":"MESA LABORATORIES INC /CO/","issuer_ticker":"MLAB","issuer_name_source":null,"issuer_url":"/issuer/0000724004","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230.0,"shares_display":"230","price_per_share":174.975,"price_display":"174.98","price_state":"stated","total_value":40244.25,"total_display":"40,244.25","total_whole":"40,244","shares_owned_after":957.0,"shares_owned_after_display":"957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-09","scope":"insider"},{"id":4264645,"accession":"0001652252-17-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652252-17-000108","line_url":"/filing/0001652252-17-000108#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1245.0,"shares_display":"1,245","price_per_share":221.1969,"price_display":"221.20","price_state":"stated","total_value":275390.1405,"total_display":"275,390.14","total_whole":"275,390","shares_owned_after":564.5691,"shares_owned_after_display":"564.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-14","scope":"insider"},{"id":4957788,"accession":"0001652252-17-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652252-17-000035","line_url":"/filing/0001652252-17-000035#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":222.6517,"price_display":"222.65","price_state":"stated","total_value":200386.53,"total_display":"200,386.53","total_whole":"200,387","shares_owned_after":560.1019,"shares_owned_after_display":"560.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-31","filed_date":"2017-06-01","scope":"insider"},{"id":2191589,"accession":"0001652252-16-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-16-000142","line_url":"/filing/0001652252-16-000142#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":165.62,"price_display":"165.62","price_state":"stated","total_value":13912.08,"total_display":"13,912.08","total_whole":"13,912","shares_owned_after":1390.1053,"shares_owned_after_display":"1,390.11","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-08","scope":"insider"},{"id":2140172,"accession":"0001652252-16-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-16-000116","line_url":"/filing/0001652252-16-000116#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":158.0791,"price_display":"158.08","price_state":"stated","total_value":14543.2772,"total_display":"14,543.28","total_whole":"14,543","shares_owned_after":1241.012,"shares_owned_after_display":"1,241.01","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-14","scope":"insider"},{"id":2858413,"accession":"0001652252-16-000106","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-16-000106","line_url":"/filing/0001652252-16-000106#line-3","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":414.0,"shares_display":"414","price_per_share":155.0169,"price_display":"155.02","price_state":"stated","total_value":64176.9966,"total_display":"64,177.00","total_whole":"64,177","shares_owned_after":1093.012,"shares_owned_after_display":"1,093.01","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-12","filed_date":"2016-09-13","scope":"insider"},{"id":3017821,"accession":"0001652252-16-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-16-000075","line_url":"/filing/0001652252-16-000075","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1572.4085,"shares_display":"1,572.41","price_per_share":145.2935793306892,"price_display":"145.29","price_state":"stated","total_value":228460.859135,"total_display":"228,460.86","total_whole":"228,461","shares_owned_after":617.1974,"shares_owned_after_display":"617.20","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-14","scope":"insider","n_lines":2},{"id":8387967,"accession":"0001652252-15-000041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-15-000041","line_url":"/filing/0001652252-15-000041#line-3","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182.0,"shares_display":"182","price_per_share":139.11,"price_display":"139.11","price_state":"stated","total_value":25318.02,"total_display":"25,318.02","total_whole":"25,318","shares_owned_after":1675.2707,"shares_owned_after_display":"1,675.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-14","filed_date":"2015-09-15","scope":"insider"},{"id":8167512,"accession":"0001652252-15-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-15-000023","line_url":"/filing/0001652252-15-000023#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":137.5,"price_display":"137.50","price_state":"stated","total_value":12650.0,"total_display":"12,650.00","total_whole":"12,650","shares_owned_after":1377.2707,"shares_owned_after_display":"1,377.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-11","filed_date":"2015-09-14","scope":"insider"},{"id":8552660,"accession":"0001652252-15-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-15-000018","line_url":"/filing/0001652252-15-000018#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001621222","owner_name":"Hall Shannon","owner_display_name":"Hall Shannon","owner_url":"/insider/0001621222","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":139.01,"price_display":"139.01","price_state":"stated","total_value":11676.84,"total_display":"11,676.84","total_whole":"11,677","shares_owned_after":1229.2707,"shares_owned_after_display":"1,229.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-09","filed_date":"2015-09-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000724004","name":"MESA LABORATORIES INC /CO/","url":"/issuer/0000724004","role":"Director","n_filings":1,"first_seen":"2022-12-09","last_seen":"2022-12-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000012208","name":"BIO RAD LABORATORIES INC","url":"/issuer/0000012208","role":"Officer (Executive Vice President)","n_filings":9,"first_seen":"2015-09-10","last_seen":"2017-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001621222","retrieved_at":"2026-08-25T22:13:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}